Eyenovia Short Term Debt vs Common Stock Analysis

EYEN Stock

USD 0.53 0.01 1.85%

Eyenovia financial indicator trend analysis is much more than just examining Eyenovia latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Eyenovia is a good investment. Please check the relationship between Eyenovia Short Term Debt and its Common Stock accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eyenovia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.

Short Term Debt vs Common Stock

Short Term Debt vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Eyenovia Short Term Debt account and Common Stock. At this time, the significance of the direction appears to have strong relationship.

The correlation between Eyenovia's Short Term Debt and Common Stock is 0.69. Overlapping area represents the amount of variation of Short Term Debt that can explain the historical movement of Common Stock in the same time period over historical financial statements of Eyenovia, assuming nothing else is changed. The correlation between historical values of Eyenovia's Short Term Debt and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Short Term Debt of Eyenovia are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Short Term Debt i.e., Eyenovia's Short Term Debt and Common Stock go up and down completely randomly.

Correlation Coefficient

0.69

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Short Term Debt

Common Stock

Most indicators from Eyenovia's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Eyenovia current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eyenovia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.As of the 24th of October 2024, Sales General And Administrative To Revenue is likely to grow to 2,828, while Selling General Administrative is likely to drop about 7.3 M.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	221.6K	307.4K	783.2K	822.4K
Interest Income	2.5K	83.3K	547.6K	574.9K

Depreciation And Amortization Interest Income

Eyenovia fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Property Plant Equipment	Other Assets	Retained Earnings Total Equity	Deferred Long Term Liab	Net Invested Capital
Total Assets		0.53	0.87	0.91	0.91	0.6	-0.58	-0.86	0.93	0.96	0.61	0.96	0.93	0.82	0.93	0.44	0.93	0.87	0.55	0.96	0.85	0.78	0.68	-0.97	-0.93	0.94
Other Current Liab	0.53		0.15	0.51	0.75	0.77	-0.03	-0.75	0.66	0.52	0.54	0.52	0.66	0.61	0.67	0.21	0.67	0.57	0.73	0.49	0.74	0.65	0.65	-0.63	-0.69	0.64
Total Current Liabilities	0.87	0.15		0.7	0.7	0.4	-0.6	-0.67	0.74	0.83	0.5	0.83	0.8	0.65	0.79	0.55	0.73	0.82	0.39	0.85	0.68	0.58	0.44	-0.81	-0.74	0.69
Total Stockholder Equity	0.91	0.51	0.7		0.85	0.41	-0.69	-0.7	0.9	0.94	0.47	0.94	0.82	0.59	0.83	0.26	0.78	0.66	0.36	0.92	0.7	0.64	0.55	-0.92	-0.92	0.9
Net Tangible Assets	0.91	0.75	0.7	0.85		0.81	-0.32	-0.95	0.92	0.85	0.81	0.85	0.96	0.82	0.97	0.57	0.92	0.89	0.78	0.84	0.95	0.89	0.83	-0.95	-0.94	0.95
Property Plant And Equipment Net	0.6	0.77	0.4	0.41	0.81		0.24	-0.92	0.58	0.45	0.89	0.45	0.79	0.82	0.79	0.66	0.76	0.84	0.99	0.46	0.92	0.92	0.92	-0.66	-0.62	0.72
Net Debt	-0.58	-0.03	-0.6	-0.69	-0.32	0.24		0.13	-0.55	-0.75	0.24	-0.75	-0.34	-0.09	-0.36	0.23	-0.33	-0.23	0.29	-0.74	-0.13	0.03	0.18	0.53	0.55	-0.36
Retained Earnings	-0.86	-0.75	-0.67	-0.7	-0.95	-0.92	0.13		-0.83	-0.75	-0.86	-0.75	-0.97	-0.91	-0.96	-0.63	-0.94	-0.94	-0.89	-0.75	-1.0	-0.96	-0.9	0.89	0.86	-0.9
Accounts Payable	0.93	0.66	0.74	0.9	0.92	0.58	-0.55	-0.83		0.9	0.6	0.9	0.91	0.75	0.92	0.43	0.9	0.77	0.55	0.88	0.82	0.72	0.62	-0.96	-0.99	0.9
Cash	0.96	0.52	0.83	0.94	0.85	0.45	-0.75	-0.75	0.9		0.42	1.0	0.86	0.65	0.87	0.27	0.82	0.78	0.4	1.0	0.75	0.62	0.49	-0.95	-0.93	0.85
Non Current Assets Total	0.61	0.54	0.5	0.47	0.81	0.89	0.24	-0.86	0.6	0.42		0.42	0.79	0.77	0.78	0.84	0.72	0.79	0.92	0.42	0.87	0.93	0.93	-0.66	-0.62	0.75
Cash And Short Term Investments	0.96	0.52	0.83	0.94	0.85	0.45	-0.75	-0.75	0.9	1.0	0.42		0.86	0.65	0.87	0.27	0.82	0.78	0.4	1.0	0.75	0.62	0.49	-0.95	-0.93	0.85
Common Stock Total Equity	0.93	0.66	0.8	0.82	0.96	0.79	-0.34	-0.97	0.91	0.86	0.79	0.86		0.86	1.0	0.62	0.94	0.95	0.77	0.87	0.97	0.9	0.81	-0.97	-0.93	0.92
Common Stock Shares Outstanding	0.82	0.61	0.65	0.59	0.82	0.82	-0.09	-0.91	0.75	0.65	0.77	0.65	0.86		0.84	0.54	0.96	0.85	0.78	0.67	0.89	0.9	0.86	-0.79	-0.72	0.86
Capital Surpluse	0.93	0.67	0.79	0.83	0.97	0.79	-0.36	-0.96	0.92	0.87	0.78	0.87	1.0	0.84		0.59	0.93	0.94	0.76	0.87	0.96	0.89	0.8	-0.97	-0.95	0.92
Other Current Assets	0.44	0.21	0.55	0.26	0.57	0.66	0.23	-0.63	0.43	0.27	0.84	0.27	0.62	0.54	0.59		0.48	0.68	0.72	0.28	0.66	0.68	0.67	-0.48	-0.44	0.5
Other Stockholder Equity	0.93	0.67	0.73	0.78	0.92	0.76	-0.33	-0.94	0.9	0.82	0.72	0.82	0.94	0.96	0.93	0.48		0.87	0.72	0.83	0.92	0.88	0.81	-0.92	-0.88	0.94
Total Liab	0.87	0.57	0.82	0.66	0.89	0.84	-0.23	-0.94	0.77	0.78	0.79	0.78	0.95	0.85	0.94	0.68	0.87		0.82	0.8	0.95	0.88	0.79	-0.87	-0.81	0.82
Property Plant And Equipment Gross	0.55	0.73	0.39	0.36	0.78	0.99	0.29	-0.89	0.55	0.4	0.92	0.4	0.77	0.78	0.76	0.72	0.72	0.82		0.41	0.9	0.89	0.9	-0.62	-0.59	0.67
Total Current Assets	0.96	0.49	0.85	0.92	0.84	0.46	-0.74	-0.75	0.88	1.0	0.42	1.0	0.87	0.67	0.87	0.28	0.83	0.8	0.41		0.75	0.63	0.51	-0.94	-0.91	0.84
Common Stock	0.85	0.74	0.68	0.7	0.95	0.92	-0.13	-1.0	0.82	0.75	0.87	0.75	0.97	0.89	0.96	0.66	0.92	0.95	0.9	0.75		0.96	0.9	-0.9	-0.86	0.89
Property Plant Equipment	0.78	0.65	0.58	0.64	0.89	0.92	0.03	-0.96	0.72	0.62	0.93	0.62	0.9	0.9	0.89	0.68	0.88	0.88	0.89	0.63	0.96		0.98	-0.81	-0.74	0.89
Other Assets	0.68	0.65	0.44	0.55	0.83	0.92	0.18	-0.9	0.62	0.49	0.93	0.49	0.81	0.86	0.8	0.67	0.81	0.79	0.9	0.51	0.9	0.98		-0.71	-0.64	0.84
Retained Earnings Total Equity	-0.97	-0.63	-0.81	-0.92	-0.95	-0.66	0.53	0.89	-0.96	-0.95	-0.66	-0.95	-0.97	-0.79	-0.97	-0.48	-0.92	-0.87	-0.62	-0.94	-0.9	-0.81	-0.71		0.98	-0.94
Deferred Long Term Liab	-0.93	-0.69	-0.74	-0.92	-0.94	-0.62	0.55	0.86	-0.99	-0.93	-0.62	-0.93	-0.93	-0.72	-0.95	-0.44	-0.88	-0.81	-0.59	-0.91	-0.86	-0.74	-0.64	0.98		-0.9
Net Invested Capital	0.94	0.64	0.69	0.9	0.95	0.72	-0.36	-0.9	0.9	0.85	0.75	0.85	0.92	0.86	0.92	0.5	0.94	0.82	0.67	0.84	0.89	0.89	0.84	-0.94	-0.9

Click cells to compare fundamentals

Eyenovia Account Relationship Matchups

Eyenovia fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	14.7M	33.9M	31.7M	31.0M	28.8M	21.0M
Other Current Liab	1.3M	1.6K	42.4K	2.3M	1.9M	2.0M
Total Current Liabilities	2.9M	18.2M	11.2M	4.5M	9.5M	6.2M
Total Stockholder Equity	11.7M	15.3M	20.5M	17.2M	9.0M	12.4M
Net Tangible Assets	16.9M	11.7M	15.3M	20.5M	23.5M	24.7M
Property Plant And Equipment Net	230.5K	396.4K	1.3M	3.3M	5.0M	5.3M
Net Debt	(14.1M)	(27.9M)	(12.3M)	(12.7M)	1.3M	1.3M
Retained Earnings	(57.7M)	(77.4M)	(90.2M)	(118.2M)	(145.5M)	(138.2M)
Accounts Payable	1.5M	1.5M	1.6M	1.4M	1.8M	1.2M
Cash	14.2M	28.4M	19.5M	22.9M	14.8M	16.0M
Non Current Assets Total	348.3K	515.4K	9.7M	3.4M	12.3M	12.9M
Cash And Short Term Investments	14.2M	28.4M	19.5M	22.9M	14.8M	16.0M
Common Stock Total Equity	257.0	1.1K	1.7K	2.5K	2.9K	3.0K
Common Stock Shares Outstanding	14.3M	21.1M	26.3M	33.6M	41.0M	21.5M
Liabilities And Stockholders Equity	14.7M	33.9M	31.7M	31.0M	28.8M	21.0M
Capital Surpluse	24.4M	53.4M	69.4M	92.7M	106.7M	112.0M
Other Current Assets	196.7K	453.5K	734.9K	26.7K	866.6K	909.9K
Other Stockholder Equity	69.4M	92.7M	110.7M	135.5M	154.5M	82.0M
Total Liab	3.0M	18.6M	11.2M	13.8M	19.8M	20.8M
Property Plant And Equipment Gross	230.5K	396.4K	1.6M	3.3M	7.2M	7.5M
Total Current Assets	14.3M	33.4M	22.0M	27.6M	16.4M	17.7M
Common Stock	1.7K	2.5K	2.8K	3.7K	4.6K	4.8K
Property Plant Equipment	36.7K	230.5K	396.4K	1.3M	1.5M	1.5M
Non Current Liabilities Total	45.4K	404.5K	19.9K	9.3M	10.2M	10.8M
Net Invested Capital	11.7M	15.8M	27.6M	26.0M	23.3M	19.9M
Net Working Capital	11.4M	15.2M	10.8M	23.1M	11.2M	14.7M
Capital Stock	1.7K	2.5K	2.8K	3.7K	4.6K	3.0K

Pair Trading with Eyenovia

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Eyenovia position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eyenovia will appreciate offsetting losses from the drop in the long position's value.

Moving together with Eyenovia Stock

0.63	VCNX	Vaccinex	Pair Corr
0.61	DRMA	Dermata Therapeutics	Pair Corr

Moving against Eyenovia Stock

0.86	EXAS	EXACT Sciences	Pair Corr
0.75	LLY	Eli Lilly	Pair Corr
0.7	EXEL	Exelixis	Pair Corr
0.64	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.61	BMY	Bristol Myers Squibb	Pair Corr

The ability to find closely correlated positions to Eyenovia could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eyenovia when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eyenovia - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eyenovia to buy it.

The correlation of Eyenovia is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eyenovia moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eyenovia moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Eyenovia can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Eyenovia offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eyenovia's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eyenovia Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eyenovia Stock:

How To Invest In Eyenovia

Details

Is Eyenovia Stock a good investment?

Details

What is Eyenovia's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Eyenovia. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Eyenovia Stock, please use our How to Invest in Eyenovia guide.

You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eyenovia. If investors know Eyenovia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eyenovia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.78)

Revenue Per Share

0.001

Quarterly Revenue Growth

Return On Assets

(0.93)

Return On Equity

(9.15)

The market value of Eyenovia is measured differently than its book value, which is the value of Eyenovia that is recorded on the company's balance sheet. Investors also form their own opinion of Eyenovia's value that differs from its market value or its book value, called intrinsic value, which is Eyenovia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eyenovia's market value can be influenced by many factors that don't directly affect Eyenovia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Eyenovia's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eyenovia is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eyenovia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Eyenovia Short Term Debt vs Common Stock Analysis

Short Term Debt vs Common Stock

Short Term Debt vs Common Stock Correlation Analysis

Correlation Coefficient

Short Term Debt

Common Stock

Eyenovia fundamental ratios Correlations

Eyenovia Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Eyenovia fundamental ratios Accounts

Pair Trading with Eyenovia

Moving together with Eyenovia Stock

Moving against Eyenovia Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Capital Surpluse	+ 1.0	Common Stock Total Equity
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Other Assets	+ 0.98	Property Plant Equipment

Common Stock	- 1.0	Retained Earnings
Deferred Long Term Liab	- 0.99	Accounts Payable
Retained Earnings Total Equity	- 0.97	Capital Surpluse
Retained Earnings Total Equity	- 0.97	Common Stock Total Equity
Common Stock Total Equity	- 0.97	Retained Earnings
Retained Earnings Total Equity	- 0.97	Total Assets